Tag Archives: MDR cancer

exosome

Exosomes Deliver Potent Chemotherapeutic Agent to Cancer Cells

Researchers from the University of North Carolina (UNC) at Chapel Hill have increased the effectiveness of a chemotherapeutic agent 50 fold. The drug, paclitaxel (PTX), was introduced in exosomes that were delivered to cells and mice affected by multidrug resistant (MDR) cancer. The exosomes avoided the drug’s degradation by the immune system. The study was published in […]